Binding of CTLA-4 expressed on TREG cells to CD80 and CD86 on dendritic cells is believed to suppress T cell responses through the up-regulation of IDO expression, thus revealing another mechanism through which CTLA-4 can contribute to tumor antigen tolerance. The gene discussed is IDO1; the disease is neoplasm.